| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Canadian Journal of Anesthesia, Vol 38, 996-1004, Copyright © 1991 by Canadian Anesthesiologists' Society
ARTICLES |
RI Hall, JT Murphy, EA Moffitt, R Landymore, PT Pollak and L Poole
Department of Anaesthesia, Victoria General Hospital, Dalhousie University, Halifax, Nova Scotia, Canada.
The purpose of this study was to compare propofol-sufentanil with enflurane-sufentanil anaesthesia for patients undergoing elective coronary artery bypass graft (CABG) surgery with respect to changes in (1) haemodynamic variables; (2) myocardial blood flow and metabolism; (3) serum cortisol, triglyceride, lipoprotein concentrations and liver function; and (4) recovery characteristics. Forty-seven patients with preserved ventricular function (ejection fraction greater than 40%, left ventricular end diastolic pressure less than or equal to 16 mmHg) were studied. Patients in Group A (n = 24) received sufentanil 0.2 microgram.kg-1 and propofol 1-2 mg.kg-1 for induction of anaesthesia which was maintained with a variable rate propofol (50-200 micrograms.kg-1.min-1) infusion and supplemental sufentanil (maximum total 5 micrograms.kg-1). Patients in Group B (n = 23) received sufentanil 5 micrograms.kg-1 for induction of anaesthesia which was maintained with enflurane and supplemental sufentanil (maximum total 7 micrograms.kg-1). Haemodynamic and myocardial metabolic profiles were determined at the awake-sedated, post-induction, post-intubation, first skin incision, post-sternotomy, and pre-cardiopulmonary bypass intervals. Induction of anaesthesia produced a larger reduction in systolic blood pressure in Group A (156 +/- 22 to 104 +/- 20 mmHg vs 152 +/- 26 to 124 +/- 24 mmHg; P less than 0.05). No statistical differences were detected at any other time or in any other variable including myocardial lactate production (n = 13 events in each group), time to tracheal extubation and time to discharge from the ICU. We concluded that, apart from hypotension on induction of anaesthesia, propofol-sufentanil anaesthesia produced anaesthetic conditions equivalent to enflurane-sufentanil anaesthesia for CABG surgery.
This article has been cited by other articles:
![]() |
C. H. Yu and W. S. Beattie The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG: a meta-analysis: [Les effets des anesthesiques volatils sur les complications ischemiques et la mortalite cardiaques pendant le PAC : une meta-analyse]. Can J Anesth, September 1, 2006; 53(9): 906 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Symons and P. S. Myles Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis Br. J. Anaesth., August 1, 2006; 97(2): 127 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hofland, I. Gultuna, and R. Tenbrinck Xenon anaesthesia for laparoscopic cholecystectomy in a patient with Eisenmenger's syndrome{{dagger}} Br. J. Anaesth., June 1, 2001; 86(6): 882 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Williams, T. K. Jones, K. A. Hanson, and J. P. Morray The Hemodynamic Effects of Propofol in Children with Congenital Heart Disease Anesth. Analg., December 1, 1999; 89(6): 1411 - 1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Wouters, M. Van de Velde, and J. Van Hemelrijck Cardiovascular Effects of Propofol Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1997; 1(2): 121 - 131. [PDF] |
||||
![]() |
J. D. Swenson and P. L. Bailey Opioids in Cardiovascular Anesthesia Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1997; 1(2): 146 - 163. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |